The Ryanodine Receptor in Cardiac Physiology and Disease

Advances in Pharmacology

Volumn 59, Issue C, 2010, Pages 1-30

  Kushnir, Alexander ^a   Marks, Andrew R ^a,b  

^a College of Physicians and Surgeons of Columbia University ^*  (United States)

^b Russ Berrie Medical Sciences Pavilion ^*  (United States)

Author keywords

Excitation contraction coupling; Heart failure; Ryanodine receptor

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; BETA ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CALMODULIN; CALSEQUESTRIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DANTROLENE; FK 506 BINDING PROTEIN; FLECAINIDE; PHOSPHODIESTERASE IV; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; RYANODINE RECEPTOR; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 2; SORCIN; CARDIOVASCULAR AGENT;

BOOK; CALCIUM TRANSPORT; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; DRUG TARGETING; ENZYME PHOSPHORYLATION; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; SARCOPLASMIC RETICULUM; SUDDEN INFANT DEATH SYNDROME; ANIMAL; ATRIAL FIBRILLATION; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; GENETICS; HEART CONTRACTION; HEART MUSCLE CONDUCTION SYSTEM; METABOLISM; NEWBORN; PHOSPHORYLATION; PHYSIOLOGY; SUDDEN INFANT DEATH; TACHYCARDIA, VENTRICULAR;

ANIMALS; ATRIAL FIBRILLATION; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARDIOVASCULAR AGENTS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG DESIGN; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; INFANT, NEWBORN; MYOCARDIAL CONTRACTION; PHOSPHORYLATION; RECEPTORS, ADRENERGIC, BETA; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SUDDEN INFANT DEATH; TACHYCARDIA, VENTRICULAR; TACROLIMUS BINDING PROTEINS;

EID: 77957373124     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(10)59001-X     Document Type: Chapter

References (170)

1. 2+ leak in heart failure. Circulation Research 2005, 97(12):1314-1322.
2. Aracena P., Tang W., Hamilton S.L., et al. Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels. Antioxidants and Redox Signaling 2005, 7(7-8):870-881.
3. Balshaw D., Gao L., Meissner G. Luminal loop of the ryanodine receptor: A pore-forming segment?. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(7):3345-3347.
4. Bean B.P. Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology. The Journal of General Physiology 1985, 86(1):1-30.
5. Bellinger A.M., Reiken S., Carlson C., et al. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nature Medicine 2009, 15(3):325-330.
6. Bellinger A.M., Reiken S., Dura M., et al. Remodeling of ryanodine receptor complex causes "leaky" channels: A molecular mechanism for decreased exercise capacity. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(6):2198-2202.
7. Benkusky N.A., Weber C.S., Scherman J.A., et al. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circulation Research 2007, 101(8):819-829.
8. Blayney L.M., Jones J.L., Griffiths J., et al. A mechanism of ryanodine receptor modulation by FKBP12/12.6, protein kinase A, and K201. Cardiovascular Research 2010, 85(1):68-78.
9. Brillantes A.B., Ondrias K., Scott A., et al. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 1994, 77(4):513-523.
10. Bristow M.R., Ginsburg R., Minobe W., et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. The New England Journal of Medicine 1982, 307(4):205-211.
11. Campbell D.L., Giles W.R., Hume J.R., et al. Inactivation of calcium current in bull-frog atrial myocytes. Journal of Physiology 1988, 403:287-315.
12. Carlisle Michel J.J., Dodge K.L., Wong W., et al. PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex. The Biochemical Journal 2004, 381(Pt 3):587-592.
13. 2+ leak promotes atrial fibrillation in mice. The Journal of Clinical Investigation 2009, 119(7):1940-1951.
14. Chen Z., Li Z., Wei B., et al. FKBP12.6-Knockout mice display hyperinsulinemia and resistance to high-fat diet-induced hyperglycemia. The FASEB Journal 2010, 24(2):357-363.
15. Ching L.L., Williams A.J., Sitsapesan R. Evidence for ca(2+) activation and inactivation sites on the luminal side of the cardiac ryanodine receptor complex. Circulation Research 2000, 87(3):201-206.
16. 2+ gating of skeletal muscle and cardiac ryanodine receptors. Biophysical Journal 1997, 73(1):141-156.
17. Couchonnal L.F., Anderson M.E. The role of calmodulin kinase II in myocardial physiology and disease. Physiology (Bethesda) 2008, 23:151-159.
18. 2+ oscillations. Science 1998, 279(5348):227-230.
19. del Monte F., Harding S.E., Schmidt U., et al. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 1999, 100(23):2308-2311.
20. Dodge K.L., Khouangsathiene S., Kapiloff M.S., et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO Journal 2001, 20(8):1921-1930.
21. Draper M.H., Weidmann S. Cardiac resting and action potentials recorded with an intracellular electrode. Journal of Physiology (Paris) 1951, 115(1):74-94.
22. 2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1). Proceedings of the National Academy of Sciences of the United States of America 2002, 99(26):16725-16730.
23. Ebashi S., Lipmann F. Adenosine triphosphate-linked concentration of calcium ions in a particulate fraction of rabbit muscle. Journal of Cell Biology 1962, 14(3):389-400.
24. Edwards G.A., Weiant E.A., Slocombe A.G., et al. The action of ryanodine on the contractile process in striated muscle. Science 1948, 108(2804):330-332.
25. Estrada-Quintero T., Uretsky B.F., Murali S., et al. Neurohormonal activation and exercise function in patients with severe heart failure and patients with left ventricular assist system. A comparative study. Chest 1995, 107(6):1499-1503.
26. Farrell E.F., Antaramian A., Benkusky N., et al. Regulation of cardiac excitation-contraction coupling by sorcin, a novel modulator of ryanodine receptors. Biological Research 2004, 37(4):609-612.
27. Farrell E.F., Antaramian A., Rueda A., et al. Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. The Journal of Biological Chemistry 2003, 278(36):34660-34666.
28. Fauconnier J., Thireau J., Reiken S., et al. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(4):1559-1564.
29. 2+ release kinetics during beta-adrenergic stimulation. Journal of Molecular and Cellular Cardiology 2007, 43(3):281-291.
30. Fill M., Copello J.A. Ryanodine receptor calcium release channels. Physiological Reviews 2002, 82(4):893-922.
31. 2+ release channels with ryanodine in junctional terminal cisternae of sarcoplasmic reticulum of fast skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America 1985, 82(21):7256-7259.
32. Gaburjakova M., Gaburjakova J., Reiken S., et al. FKBP12 binding modulates ryanodine receptor channel gating. The Journal of Biological Chemistry 2001, 276(20):16931-16935.
33. Gellen B., Fernandez-Velasco M., Briec F., et al. Conditional FKBP12.6 Overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation 2008, 117(14):1778-1786.
34. George C.H., Higgs G.V., Lai F.A. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circulation Research 2003, 93(6):531-540.
35. Gibbons W.R., Zygmunt A.C. Excitation-contraction coupling in heart. The heart and cardiovascular system 1992, 1249-1279. Raven Press, Ltd, New York. 2nd ed. H.A. Fozzard (Ed.).
36. 2+ current trigger. Journal of Physiology (Paris) 2004, 556(Pt 2):463-480.
37. 2+ sensing sites. Biophysical Journal 1998, 75(6):2801-2810.
38. Gyorke S., Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovascular Research 2008, 77(2):245-255.
39. Hasselbach W., Makinose M. The calcium pump of the "relaxing granules" of muscle and its dependence on ATP-splitting. Biochemische Zeitschrift 1961, 333:518-528.
40. Hasselbach W., Makinose M. On the mechanism of calcium transport across the membrane of the sarcoplasmic reticulum. Biochemische Zeitschrift 1963, 339:94-111.
41. 2+ spark mass. Journal of Molecular and Cellular Cardiology 2010, 48(2):293-301.
42. Hobai I.A., O'Rourke B. Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure. Circulation 2001, 103(11):1577-1584.
43. 2+ /calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circulation Research 1999, 84(6):713-721.
44. 2+ regulation in chronic rat heart failure. Journal of Physiological Sciences 2010, 60(2):85-94.
45. Huang F., Shan J., Reiken S., et al. Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: Rescue of heart failure by calstabin2 in mice. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(9):3456-3461.
46. Huke S., Bers D.M. Ryanodine receptor phosphorylation at serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochemical and Biophysical Research Communications 2008, 376(1):80-85.
47. 2+ release and [3h]ryanodine binding to RyR2 irrespective of FKBP12.6 Association. The Biochemical Journal 2007, 404(3):431-438.
48. Inagaki K., Kihara Y., Hayashida W., et al. Anti-ischemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of delta-isoform of protein kinase C in rat ventricular myocardium. Circulation 2000, 101(7):797-804.
49. Ito K., Shigematsu S., Sato T., et al. JTV-519, a novel cardioprotective agent, improves the contractile recovery after ischaemia-reperfusion in coronary perfused guinea-pig ventricular muscles. British Journal of Pharmacology 2000, 130(4):767-776.
50. Jayaraman T., Brillantes A.M., Timerman A.P., et al. FK506 binding protein associated with the calcium release channel (ryanodine receptor). The Journal of Biological Chemistry 1992, 267(14):9474-9477.
51. Jenden D.J., Fairhurst A.S. The pharmacology of ryanodine. Pharmacological Reviews 1969, 21(1):1-25.
52. 2+ release, but normal ryanodine receptors, in canine and human heart failure. Circulation Research 2002, 91(11):1015-1022.
53. 2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circulation Research 2005, 97(11):1173-1181.
54. Johnson J.N., Tester D.J., Bass N.E., et al. Cardiac Channel Molecular Autopsy for Sudden Unexpected Death in Epilepsy. Journal of Child Neurology 2010, 25(7):916-921.
55. Jones P.P., Meng X., Xiao B., et al. Localization of PKA phosphorylation site, ser(2030), in the three-dimensional structure of cardiac ryanodine receptor. Biochemical Journal 2008, 410(2):261-270.
56. Kaftan E., Marks A.R., Ehrlich B.E. Effects of rapamycin on ryanodine receptor/Ca(2+)-release channels from cardiac muscle. Circulation Research 1996, 78(6):990-997.
57. Kaneko N. New 1,4-Benzothiazepine Derivative, K201, Demonstrates Cardioprotective Effects Against Sudden Cardiac Cell Death and lntracellular Calcium Blocking Action. Drug Development Research 1994, 33:429-438.
58. Kawabata H., Nakagawa K., Ishikawa K. A novel cardioprotective agent, JTV-519, is abolished by nitric oxide synthase inhibitor on myocardial metabolism in ischemia-reperfused rabbit hearts. Hypertension Research 2002, 25(2):303-309.
59. Kimura J., Kawahara M., Sakai E., et al. Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes. The Japanese Journal of Pharmacology 1999, 79(3):275-281.
60. 2+ for electrical cell-to-cell uncoupling and conduction block in myocardial tissue. Basic Research in Cardiology 1992, 87(Suppl 2):131-143.
61. Kobayashi S., Yano M., Suetomi T., et al. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. Journal of the American College of Cardiology 2009, 53(21):1993-2005.
62. Kohno M., Yano M., Kobayashi S., et al. A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure. American Journal of Physiology. Heart and Circulatory Physiology 2003, 284(3):H1035-H1042.
63. 2+ activation of the ryanodine receptor. The Biochemical Journal 2008, 414(3):441-452.
64. Kushnir A., Betzenhauser M.J., Marks A.R. Ryanodine receptor studies using genetically engineered mice. FEBS Letters 2010, 584(10):1956-1965.
65. Kushnir A., Shan J., Betzenhauser M.J., et al. Role of CaMKII{delta} phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(22):10274-10279.
66. Lakatta E.G. Beyond Bowditch: The convergence of cardiac chronotropy and inotropy. Cell Calcium 2004, 35(6):629-642.
67. 2+ inhibits the ryanodine receptor from cardiac muscle. Journal of Membrane Biology 1995, 147(1):7-22.
68. 2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. The Journal of Clinical Investigation 2008, 118(6):2230-2245.
69. Lehnart S.E., Wehrens X.H., Laitinen P.J., et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 2004, 109(25):3208-3214.
70. Lehnart S.E., Wehrens X.H., Marks A.R. Calstabin deficiency, ryanodine receptors, and sudden cardiac death. Biochemical and Biophysical Research Communications 2004, 322(4):1267-1279.
71. Lehnart S.E., Wehrens X.H., Reiken S., et al. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 2005, 123(1):25-35.
72. Li Y., Kranias E.G., Mignery G.A., et al. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circulation Research 2002, 90(3):309-316.
73. Li L., Satoh H., Ginsburg K.S., et al. The effect of Ca(2+)-calmodulin-dependent protein kinase II on cardiac excitation-contraction coupling in ferret ventricular myocytes. Journal of Physiology (Paris) 1997, 501(Pt 1):17-31.
74. 2+ /calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. The Journal of Clinical Investigation 2009, 119(5):1230-1240.
75. Liu Y., Porta M., Qin J., et al. Flux regulation of cardiac ryanodine receptor channels. The Journal of General Physiology 2010, 135(1):15-27.
76. Locke F.S., Rosenheim O. Contributions to the physiology of the isolated heart: The consumption of dextrose by mammalian cardiac muscle. Journal of Physiology (Paris) 1907, 36(4-5):205-220.
77. Lokuta A.J., Meyers M.B., Sander P.R., et al. Modulation of cardiac ryanodine receptors by sorcin. The Journal of Biological Chemistry 1997, 272(40):25333-25338.
78. MacDonnell S.M., Garcia-Rivas G., Scherman J.A., et al. Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808. Circulation Research 2008, 102(8):e65-e72.
79. 2+ release. Circulation Research 2003, 92(8):904-911.
80. Marks A.R. Cellular functions of immunophilins. Physiological Reviews 1996, 76(3):631-649.
81. Marx S.O., Reiken S., Hisamatsu Y., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts. Cell 2000, 101(4):365-376.
82. Marx S.O., Reiken S., Hisamatsu Y., et al. Phosphorylation-dependent regulation of ryanodine receptors: A novel role for leucine/isoleucine zippers. The Journal of Cell Biology 2001, 153(4):699-708.
83. 2+ release channels (ryanodine receptors). Science 1998, 281(5378):818-821.
84. 2+ release channel (ryanodine receptor. The Journal of Biological Chemistry 2003, 278(6):3786-3792.
85. Mathur N., Sood S., Wang S., et al. Sudden infant death syndrome in mice with an inherited mutation in RyR2. Circulation Arrhythmia and Electrophysiology 2009, 2(6):677-685.
86. 2+ release channel of sarcoplasmic reticulum. The Journal of Biological Chemistry 1986, 261(14):6300-6306.
87. 2+ and is modulated by Mg2+, adenine nucleotide, and calmodulin. The Journal of Biological Chemistry 1987, 262(7):3065-3073.
88. Meng X., Xiao B., Cai S., et al. Three-dimensional localization of serine 2808, a phosphorylation site in cardiac ryanodine receptor. The Journal of Biological Chemistry 2007, 282(35):25929-25939.
89. Mercadier J.J., Lompre A.M., Duc P., et al. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. The Journal of Clinical Investigation 1990, 85(1):305-309.
90. Nakai J., Imagawa T., Hakamat Y., et al. Primary structure and functional expression from cDNA of the cardiac ryanodine receptor/calcium release channel. FEBS Letters 1990, 271(1-2):169-177.
91. Nattel S., Burstein B., Dobrev D. Atrial remodeling and atrial fibrillation: Mechanisms and implications. Circulation Arrhythmia and Electrophysiology 2008, 1(1):62-73.
92. 2+ Levels in Right Atrial Myocardium of Patients With Atrial Fibrillation. Circulation Research 2010, 106(6):1134-1144.
93. Noguchi N., Yoshikawa T., Ikeda T., et al. FKBP12.6 disruption impairs glucose-induced insulin secretion. Biochemical and Biophysical Research Communications 2008, 371(4):735-740.
94. Oda T., Yano M., Yamamoto T., et al. Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure. Circulation 2005, 111(25):3400-3410.
95. Ogrodnik J., Niggli E. Increased Ca(2+) leak and spatiotemporal coherence of Ca(2+) release in cardiomyocytes during beta-adrenergic stimulation. Journal of Physiology (Paris) 2010, 588(Pt 1):225-242.
96. 2+ release in heart failure. Cardiovascular Research 2010, 87(4):609-617.
97. Ono K., Yano M., Ohkusa T., et al. Altered interaction of FKBP12.6 with ryanodine receptor as a cause of abnormal Ca(2+) release in heart failure. Cardiovascular Research 2000, 48(2):323-331.
98. Orlova E.V., Serysheva I.I., van Heel M., et al. Two structural configurations of the skeletal muscle calcium release channel. Nature Structural Biology 1996, 3(6):547-552.
99. 2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. The Journal of Biological Chemistry 1990, 265(23):13472-13483.
100. Otsuka M., Ebashi F., Imai S. Cardiac myosin B and calcium ions. The Journal of Biochemistry 1964, 55:192-194.
101. Oudit G.Y., Ramirez R.J., Backx P.H. Voltage-regulated potassium channels. Cardiac electrophysiology from cell to bedside 2004, 19-32. Saunders, Philadelphia, PA. 4th ed. D.P. Zipes (Ed.).
102. 2+ /calmodulin kinase signalling pathway in rat cardiac myocytes. Journal of Physiology (Paris) 2007, 583(Pt 2):685-694.
103. Pogwizd S.M., Bers D.M. Cellular basis of triggered arrhythmias in heart failure. Trends in Cardiovascular Medicine 2004, 14(2):61-66.
104. Priori S.G., Napolitano C., Tiso N., et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001, 103(2):196-200.
105. Reiken S., Gaburjakova M., Gaburjakova J., et al. Beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure. Circulation 2001, 104(23):2843-2848.
106. Reiken S., Wehrens X.H., Vest J.A., et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 2003, 107(19):2459-2466.
107. Ringer S. A further Contribution regarding the influence of the different Constituents of the Blood on the Contraction of the Heart. Journal of Physiology (Paris) 1883, 4(1):29-42.
108. Rodriguez P., Bhogal M.S., Colyer J. Stoichiometric phosphorylation of cardiac ryanodine receptor on serine 2809 by calmodulin-dependent kinase II and protein kinase A. The Journal of Biological Chemistry 2003, 278(40):38593-38600.
109. Rogers E.F., Koniuszy F.R., et al. Plant insecticides; ryanodine, a new alkaloid from Ryania speciosa Vahl. Journal of the American Chemical Society 1948, 70(9):3086-3088.
110. Rohr S. Role of gap junctions in the propagation of the cardiac action potential. Cardiovascular Research 2004, 62(2):309-322.
111. Samso M., Feng W., Pessah I.N., et al. Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biology 2009, 7(4):e85.
112. Samso M., Wagenknecht T., Allen P.D. Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo-EM. Nature Structural & Molecular Biology 2005, 12(6):539-544.
113. Sette C., Conti M. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. The Journal of Biological Chemistry 1996, 271(28):16526-16534.
114. Song L.S., Wang S.Q., Xiao R.P., et al. Beta-adrenergic stimulation synchronizes intracellular Ca(2+) release during excitation-contraction coupling in cardiac myocytes. Circulation Research 2001, 88(8):794-801.
115. Sood S., Chelu M.G., van Oort R.J., et al. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm 2008, 5(7):1047-1054.
116. Stange M., Xu L., Balshaw D., et al. Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. The Journal of Biological Chemistry 2003, 278(51):51693-51702.
117. Sun H., Gaspo R., Leblanc N., et al. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia. Circulation 1998, 98(7):719-727.
118. Swan H., Piippo K., Viitasalo M., et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. Journal of American College of Cardiology 1999, 34(7):2035-2042.
119. Takasago T., Imagawa T., Furukawa K., et al. Regulation of the cardiac ryanodine receptor by protein kinase-dependent phosphorylation. Journal of Biochemistry 1991, 109(1):163-170.
120. Takasago T., Imagawa T., Shigekawa M. Phosphorylation of the cardiac ryanodine receptor by cAMP-dependent protein kinase. Journal of Biochemistry 1989, 106(5):872-877.
121. 2+ leak in chronic heart failure. Circulation Research 2008, 103(12):1466-1472.
122. Tester D.J., Dura M., Carturan E., et al. A mechanism for sudden infant death syndrome (SIDS): Stress-induced leak via ryanodine receptors. Heart Rhythm 2007, 4(6):733-739.
123. Timerman A.P., Jayaraman T., Wiederrecht G., et al. The ryanodine receptor from canine heart sarcoplasmic reticulum is associated with a novel FK-506 binding protein. Biochemical and Biophysical Research Communications 1994, 198(2):701-706.
124. Timerman A.P., Onoue H., Xin H.B., et al. Selective binding of FKBP12.6 by the cardiac ryanodine receptor. The Journal of Biological Chemistry 1996, 271(34):20385-20391.
125. Timerman A.P., Wiederrecht G., Marcy A., et al. Characterization of an exchange reaction between soluble FKBP-12 and the FKBP-ryanodine receptor complex. Modulation by FKBP mutants deficient in peptidyl-prolyl isomerase activity. The Journal of Biological Chemistry 1995, 270(6):2451-2459.
126. 2+ fluxes in rat ventricular myocytes. Journal of Physiology (Paris) 2000, 522(Pt 2):259-270.
127. 2+ release channel. Biophysical Journal 1996, 70(6):2600-2615.
128. Uchinoumi H., Yano M., Suetomi T., et al. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. Circulation Research 2010, 106(8):1413-1424.
129. Valdivia H.H., Kaplan J.H., Ellis-Davies G.C., et al. Rapid adaptation of cardiac ryanodine receptors: Mfodulation by Mg2+ and phosphorylation. Science 1995, 267(5206):1997-2000.
130. Venetucci L.A., Trafford A.W., Eisner D.A. Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: Threshold sarcoplasmic reticulum calcium content is required. Circulation Research 2007, 100(1):105-111.
131. Vest J.A., Wehrens X.H., Reiken S.R., et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005, 111(16):2025-2032.
132. Vinogradova T.M., Bogdanov K.Y., Lakatta E.G. beta-Adrenergic stimulation modulates ryanodine receptor Ca(2+) release during diastolic depolarization to accelerate pacemaker activity in rabbit sinoatrial nodal cells. Circulation Research 2002, 90(1):73-79.
133. Wang W., Wehrens X.H. Stress synchronizes calcium release and promotes SR calcium leak. Journal of Physiology (Paris) 2010, 588(Pt 3):391-392.
134. Watanabe H., Chopra N., Laver D., et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nature Medicine 2009, 15(4):380-383.
135. Weber A. On the role of calcium in the activity of adenosine 5'-triphosphate hydrolysis by actomyosin. The Journal of Biological Chemistry 1959, 234:2764-2769.
136. Wehrens X.H., Lehnart S.E., Huang F., et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 2003, 113(7):829-840.
137. Wehrens X.H., Lehnart S.E., Reiken S.R., et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 2004, 304(5668):292-296.
138. 2+ /calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circulation Research 2004, 94(6):e61-e70.
139. Wehrens X.H., Lehnart S.E., Reiken S., et al. Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(27):9607-9612.
140. Wehrens X.H., Lehnart S.E., Reiken S., et al. Ryanodine receptor/calcium release channel PKA phosphorylation: A critical mediator of heart failure progression. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(3):511-518.
141. Wehrens X.H., Marks A.R. Altered function and regulation of cardiac ryanodine receptors in cardiac disease. Trends in Biochemical Sciences 2003, 28(12):671-678.
142. Weidmann S. The electrical constants of Purkinje fibres. Journal of Physiology (Paris) 1952, 118(3):348-360.
143. Welch W., Rheault S., West D.J., et al. A model of the putative pore region of the cardiac ryanodine receptor channel. Biophysical Journal 2004, 87(4):2335-2351.
144. Witcher D.R., Kovacs R.J., Schulman H., et al. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. The Journal of Biological Chemistry 1991, 266(17):11144-11152.
145. Wu Y., Gao Z., Chen B., et al. Calmodulin kinase II is required for fight or flight sinoatrial node physiology. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(14):5972-5977.
146. Xiao B., Jiang M.T., Zhao M., et al. Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure. Circulation Research 2005, 96(8):847-855.
147. 2+ -release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6). Circulation Research 2004, 94(4):487-495.
148. Xiao J., Tian X., Jones P.P., et al. Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias. The Journal of Biological Chemistry 2007, 282(48):34828-34838.
149. 2+ release. The Journal of Biological Chemistry 2007, 282(41):30256-30264.
150. 2+ release channel closure in rat heart. Journal of Physiology (Paris) 1997, 500(Pt 2):343-354.
151. Xin H.B., Senbonmatsu T., Cheng D.S., et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 2002, 416(6878):334-338.
152. 2+ release channel (ryanodine receptor. Biophysical Journal 2004, 86(2):797-804.
153. Xu X., Yano M., Uchinoumi H., et al. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction. Biochemical and Biophysical Research Communications 2010, 394(3):660-666.
154. Yamaguchi N., Takahashi N., Xu L., et al. Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel. The Journal of Clinical Investigation 2007, 117(5):1344-1353.
155. Yamaguchi N., Xu L., Pasek D.A., et al. Molecular basis of calmodulin binding to cardiac muscle Ca(2+) release channel (ryanodine receptor. The Journal of Biological Chemistry 2003, 278(26):23480-23486.
156. Yamamoto T., Yano M., Xu X., et al. Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts. Circulation 2008, 117(6):762-772.
157. Yano M., Kobayashi S., Kohno M., et al. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 2003, 107(3):477-484.
158. Yano M., Ono K., Ohkusa T., et al. Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure. Circulation 2000, 102(17):2131-2136.
159. Yano M., Yamamoto T., Kobayashi S., et al. Role of ryanodine receptor as a Ca(2+) regulatory center in normal and failing hearts. Journal of Cardiology 2009, 53(1):1-7.
160. Zaccolo M., Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 2002, 295(5560):1711-1715.
161. Zalk R., Lehnart S.E., Marks A.R. Modulation of the ryanodine receptor and intracellular calcium. Annual Review of Biochemistry 2007, 76:367-385.
162. Zaugg C.E., Buser P.T. When calcium turns arrhythmogenic: Intracellular calcium handling during the development of hypertrophy and heart failure. Croatian Medical Journal 2001, 42(1):24-32.
163. Zhang Y., Huang Z.J., Dai D.Z., et al. Downregulated FKBP12.6 expression and upregulated endothelin signaling contribute to elevated diastolic calcium and arrhythmogenesis in rat cardiomyopathy produced by l-thyroxin. International Journal of Cardiology 2008, 130(3):463-471.
164. Zhang L., Kelley J., Schmeisser G., et al. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. The Journal of Biological Chemistry 1997, 272(37):23389-23397.
165. Zhang R., Khoo M.S., Wu Y., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nature Medicine 2005, 11(4):409-417.
166. Zhang T., Maier L.S., Dalton N.D., et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circulation Research 2003, 92(8):912-919.
167. Zhang X., Tallini Y.N., Chen Z., et al. Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not beta-adrenergic stimulation in mouse cardiomyocytes. Cardiovascular Research 2009, 84(2):253-262.
168. 2+ release channels. Molecular mechanism and isoform selectivity. The Journal of Biological Chemistry 2001, 276(17):13810-13816.
169. 2+ channel. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(42):18028-18033.
170. Zissimopoulos S., Docrat N., Lai F.A. Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein. The Journal of Biological Chemistry 2007, 282(10):6976-6983.